MindBio Therapeutics Delivers First Prototypes of Edge AI Intoxication Detection Kiosks for Workplace Safety

MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) has announced the completion and delivery of its first prototype Edge AI Intoxication Detection Kiosks, a hardware and software platform designed to detect intoxication and fatigue through AI-powered voice analysis. The kiosks are intended for workplace environments and are being developed to help improve safety across industries where drug, alcohol and fatigue monitoring are critical.

The company said the prototypes will now undergo testing, model validation and data analysis in collaboration with industry participants, speech experts and software engineers. MindBio is targeting sectors including mining, aviation, construction, heavy transport and law enforcement, where regulatory requirements and high-volume testing needs create demand for scalable, noninvasive intoxication and fatigue detection solutions.

The AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The company is developing an enterprise platform including Edge-AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication using the human voice and AI in a range of enterprise environments. This technology could revolutionize workplace safety by providing a noninvasive, rapid, and accurate method for screening employees, potentially reducing accidents and improving compliance with safety regulations.

For more details, the full press release is available at https://ibn.fm/wySa8. The latest news and updates relating to MBQIF can be found in the company’s newsroom at https://ibn.fm/MBQIF.

The implications of this announcement are significant for workplace safety. Traditional methods of intoxication detection, such as breathalyzers or blood tests, can be invasive, time-consuming, and require trained personnel. MindBio's AI-powered voice analysis offers a noninvasive alternative that can provide results in seconds, making it suitable for high-throughput environments like mine sites, airports, and construction sites. This technology could also reduce the stigma associated with testing and encourage more frequent monitoring, leading to safer work environments.

Furthermore, the integration of Edge AI means that the analysis is performed locally on the kiosk, ensuring data privacy and reducing latency. This is crucial for industries where immediate results are necessary, such as in transportation or law enforcement. The ability to detect not only alcohol but also drug intoxication and fatigue expands the potential applications, addressing multiple safety concerns with a single device.

MindBio Therapeutics is positioned to address a growing market need as regulatory bodies increasingly mandate drug and alcohol testing in safety-sensitive industries. The successful deployment of these kiosks could set a new standard for occupational health and safety, potentially reducing the number of workplace accidents and fatalities related to impairment. As the prototypes move into testing and validation, stakeholders will be watching closely to see if the technology meets its promise of accuracy and reliability.